Document is current
Any future updates will be listed below
-
Authors
Gervin, Kristina
Kverneland, Magnhild
Nakken, Karl Otto
Rudi, Knut
Iversen, Per Ole
Landmark, Cecilie Johannessen
Selmer, Kaja Kristine
-
Funding
Funding for this research was provided by:
University of Oslo
- License Information
-
More Information
Article History
Received: 18 November 2025
Accepted: 11 February 2026
First Online: 13 March 2026
Declarations
:
: The study was approved by the Regional Committee for Medical and Health Research (2010/2326). All participants or parents/caregivers provided written informed consent before enrollment. All procedures in this study were in accordance with the Helsinki Declaration. The randomized clinical study was registered at ClinicalTrials.gov (ID: NCT01311440) on March 9, 2011.
: MK has received two honoraria from Nutricia. CJL has received speakers’ or expert group honoraria from Angelini, Eisai, Jazz and UCB Pharma. KKS has received consultant and speaker’s honoraria from Roche and OrionPharma, as well as reimbursement of travel and accommodation cost at a meeting from Kolpharma, and finally received sponsorships for arranging conferences from Desitin and Eisai AB. KON has received lecture honoraria from Desitin and Eisai. The remaining authors have nothing to disclose. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
